Protocol Summary

Protocol No.: OCR15562

Sponsor Protocol No.: TARGET-HCC

Protocol Title: A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Principal Investigator: Cabrera, Roniel

Objective: TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Phase: NA

Age Group: Adult

Age: 18 Years - N/A

Gender: All

Scope: National

Treatment:

Detailed Eligibility:
INCLUSION CRITERIA:
1. Ages 18 years old and older
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
EXCLUSION CRITERIA:
1. Inability to provide written informed consent

Applicable Conditions:

  • Liver Cancer
  • Participation Institution:

  • UF Gainesville : Alesa Flewellen
  • Contact:
    Alesa Flewellen
    Phone:
    Email: alesa.willis@ufl.edu

    More Information: View study listing on ClinicialTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT02954094